Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Melanoma × encorafenib × Clear all

Phase

Status

Completed 7 Terminated 6 Recruiting 5 Active not recruiting 5 Withdrawn 2 Unknown 2 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

Nivolumab 2 Melphalan 2 Interleukin-2 2 trametinib 1 toripalimab 1 sulforaphane 1 secukinumab 1 relatlimab 1 pembrolizumab 1 encorafenib 1 binimetinib 1 anlotinib 1 Toll-Like Receptor 1 1 Therapeutics 1 Standard of Care 1 Specimen Handling 1 Rehabilitation 1 Ipilimumab 1 Injections 1 Immune Checkpoint Inhibitors 1 Fulvestrant 1 Doxorubicin 1 Atorvastatin 1 Afatinib 1 3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07092410 2025-07-29

SuRage-EB

SRH Wald-Klinikum Gera GmbH

Phase 4 Not yet recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡